MABTAS Rituximab 100mg & 500

Strengths available : 100mg & 500mg

Dosage :  

• Administer only as an Intravenous Infusion.
• Do not administer as an intravenous push or bolus.
• Premedicate before each infusion.

Mabtas should only be administered by a healthcare professional with appropriate medical support to manage severe infusion reactions that can be fatal if they occur.

First Infusion: Initiate infusion at a rate of 50 mg/hr. In the absence of infusion toxicity, increase infusion rate by 50 mg/hr increments every 30 minutes, to a maximum of 400 mg/hr.

Subsequent Infusions: Initiate infusion at a rate of 100 mg/hr. In the absence of infusion toxicity, increase rate by 100 mg/hr increments at 30-minute intervals, to a maximum of 400 mg/hr.

Most common side effects are Headache, Weakness, Edema, Infection, Hair loss, Itching, Chills, Febrile neutropenia, Decreased white blood cell count (neutrophils), Infusion reaction.